Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
DD-026 New market for medicines: Do the suppliers meet their commitments?
by
Derain, L
, Locher, F
, Bellossi, F
, Meunier, A
, Kamel, A Bel
in
Shortages
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
DD-026 New market for medicines: Do the suppliers meet their commitments?
by
Derain, L
, Locher, F
, Bellossi, F
, Meunier, A
, Kamel, A Bel
in
Shortages
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
DD-026 New market for medicines: Do the suppliers meet their commitments?
Journal Article
DD-026 New market for medicines: Do the suppliers meet their commitments?
2016
Request Book From Autostore
and Choose the Collection Method
Overview
BackgroundPurchasing procedures in hospital are subject to the public procurement code and vary with the amounts of the purchase. The tender must be implemented when the purchase amount exceeds 200 000 Euros HT during the contract period. Although suppliers tender on estimated quantities, sometimes laboratories do not fulfil the first orders.PurposeThe objective of this study was to analyse the proportion of new markets whose orders were not honoured in the first 3 months after the beginning of the market.Material and methodsThe study focused on the local tender for generics starting in July 2015. The number of molecules for which the suppliers changed compared with the previous market were listed. The number of molecules for which the orders were not met by the contract holders in the first 3 months were also listed. Then we analysed the causes of these stock shortages. We also recorded if the upholder of the market was the best bidder or not, and if the previous market was subject to drug shortages or not.ResultsThe local market included 111 market changes. The proportion of new markets whose orders were not honoured in the first 3 months was 10%. 82% of these stock-outs concerned generics. 5 different suppliers were concerned, including 4 generic manufacturers. In 82% of cases, the successful supplier was the best bidder. 4 different causes of drug shortages were reported, the most common was a problem of quality control of raw material. In 18% of cases. the previous market was also subject to stock-outs.ConclusionDrug shortages on new markets are significant, and they may impact on quality of patient care and are time consuming for teams managing stock-outs (calls to other suppliers, orders, etc). It would be interesting to quantify the management cost of a drug shortage (human time, financial cost) and to establish indicators for the performance of suppliers that could help in the choice of future tenders.References and/or AcknowledgementsDirective 2004/18/EC of the European Parliament and of the Council of 31/03/2004 on the coordination of procedures for the award of public contracts.No conflict of interest.
Publisher
BMJ Publishing Group LTD
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.